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C BY-NC-Abstract One of the most prevalent disorders in the present society is depression. The development
of treatments for this disorder, beginning with the tricyclic antidepressants and leading to the devel-
opment of selective serotonin re-uptake inhibitors, has focused on compounds that block the func-
tion of the serotonin transporter (SERT). Quantitative structure–activity relationship has been
performed on a series of lactam fused chroman derivatives as selective 5-HT transporters, using dif-
ferent physicochemical parameters along with appropriate indicator variables. It has been found
that physicochemical parameters, such as connectivity indices 0v and 2v, molecular weight (MW),
Parachor (Pc), Balaban index (J), Wiener index (W) along with indicator variables are signiﬁcantly
correlated with activity. In this paper best results were obtained by using multiple regression anal-
ysis. Different models were generated with high values of R2 and low values of PRESS/SSY ratio.
The signiﬁcant equations were statistically tested by using leave one out (LOO) technique and cross-
validation methods.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.Open access under CC BY-NC-ND license.1. Introduction
5-HT transporters (serotonin transporters, SERT) are sodium-
and chloride-dependent members of the solute carrier family 6rediffmail.com (N. Shukla).
y. Production and hosting by
Saud University.
lsevier
ND license.(SLC6) found widely distributed throughout the brain. They
are responsible for the re-uptake of 5-HT and undergo a con-
formational change to move one or more molecules per cycle.
Serotonin (5-HT) stimulates smooth muscle cell growth
through 5-HT receptors and the 5-HT transporter (5-HTT),
and has been associated with pulmonary hypertension (PH).
Serotonin (5-HT) is a G-protein-coupled receptor (GPCR)
agonist, stimulates smooth muscle cell growth and migration.
This action requires both 5-HT uptake through a 5-HT active
transport process via the 5-HT transporter (5-HTT) and bind-
ing of 5-HT to one or multiple 5-HT receptors.
2. Methodology
QSAR studies have been done on a series of lactam fused chro-
man derivatives (Shen et al., 2010). The 2D structures of the
406 A.K. Srivastava, N. Shuklamolecules were drawn using Chem Sketch software (Chem
Sketch). Several physicochemical parameters were used in the
present study, which are discussed below:
2.1. Parachor (Pc)
This parameter is calculated by ACD Lab Chem Sketch Soft-
ware (Chem Sketch). The Parachor may be deﬁned as the molar
volume of a liquid at a temperature at which its surface tension
is unity. Parachor is obtained experimentally as follows:
Pc ¼ MW
d
 
c1=4
Pc is a molar volume term that is corrected by surface tension
(c) raised to the power 1/4.
2.2. Molecular weight (MW)
Molecular weight descriptor has been used as descriptor in sys-
tems such as transport studies where diffusion is the mode of
operation. It is an important variable in QSAR studies pertain-
ing to cross-resistance of various drugs in multi-drug resistant
cell lines (Liu et al., 1997; Holder et al., 2006; Carton, 1983).
2.3. Molecular connectivity (v) (Randic, 1975, 1993)
Randic index 1v= 1v(G) of G was introduced by Randic in
1975 as the connectivity index.
2.4. Balaban index(J) (Balaban, 1982, 1989, 1993, 1994, 1997)
The formerly proposed and most important distance-based
topological index is the Balaban index (J). This index is also
called distance connectivity index on average distance sum
connectivity. The Balaban index (J the average distance con-
nectivity index) is deﬁned by
J ¼ JðGÞ M
lþ 1
X
ij
ðdidjÞ0:5 ð28Þ
whereM is the number of bonds in graph G, l is the cyclomat-
ic number G and di’s (i= 1, 2, 3, . . . , N) are the distance sums
(distance degrees) of atoms in G such that
di ¼
XN
j¼1
ðDÞij2.5. Wiener index (W)
The Wiener index (W) is a widely used topological index. It is
based on the vertex-distances of the respective molecular
graph. The Wiener index (W) was proposed in 1947 by Wiener
(Weiner, 1947a,b; Lukovits, 1990, 1995; Zhu et al., 1996) and
is deﬁned as the sum of over all bonds of the product of the
number of vertices on each side of the bond.
2.6. Indicator variables (Senda and Fujita, 1991; Ismail et al.,
2002)
These are not QSAR parameters but are used to indicate the
signiﬁcance of any particular group or species at a particular
substitution site in a given series of drugs.3. Results and discussion
QSAR was performed on a series of 29 compounds of lac-
tam fused chroman derivatives as selective 5-HT transporters
with the physicochemical parameters, which are listed in
Table 1, where the biological activity (pKi) is a measure of
inhibitory activity. All the QSARs reported here were de-
rived by us and were not reported with the original dataset
taken from the literature as reference. We have used Hansch
analysis (Hansch and Leo, 1995; Hansch et al., 1995) for
developing these models. The QSAR multiple regression
analysis was performed with SPSS (7.5) version program.
Their activity data and the physicochemical parameters eval-
uated in the correlation are listed in Table 2. These param-
eters were found to be useful earlier in QSAR based drug
modeling (Srivastava et al., 2008a,b,c,d, 2009a,b,c, 2010;
Singh et al., 2008a,b).
In order to study the role of different substituents at speciﬁc
positions indicator parameters such as I1 for
O
N
(CH2)cPr
N
H O
and I2 for
O
N
i-Bu
N
H O
groups present at R1 positions were introduced and are also
listed in Table 1. Multiregression analysis of the data gave sev-
eral models of which the following equations were found to be
signiﬁcant:
pKi ¼ 0:014ð0:007ÞMVþ 0:005ð0:025ÞBAC
 1:549ð1:133ÞWAþ 0:513ð0:340ÞI2
 1:200ð0:761ÞI2 þ 21:729 ð1Þ
n ¼ 29; R ¼ 0:884; R2 ¼ 0:781; R2A ¼ 0:734;
SE ¼ 0:338; Fð5;23Þ ¼ 16:432; Q ¼ 2:615
pKi ¼ 0:023ð0:007ÞMVþ 0:028ð0:033ÞBAC
 11:715ð12:799ÞXeqþ 0:529ð0:368ÞI1
 1:276ð0:860ÞI2 þ 42:130 ð2Þ
n ¼ 29; R ¼ 0:863; R2 ¼ 0:745; R2A ¼ 0:690;
SE ¼ 0:365; Fð5;23Þ ¼ 13:443; Q ¼ 2:364
pKi ¼ 0:022ð0:007ÞMVþ 0:014ð0:028ÞBAC
 4:796ð5:845ÞDþ 0:655ð0:385ÞI1
 1:216ð0:857ÞI2 þ 20:775 ð3Þ
n ¼ 29; R ¼ 0:859; R2 ¼ 0:738; R2A ¼ 0:681;
SE ¼ 0:370; Fð5;23Þ ¼ 12:966; Q ¼ 2:322
Table 1 Biological activity, physicochemical data for lactam fused chroman derivatives.
N
H
R1
R2
S. No. R1 R2 pKi MV BAC D WA Id Xeq I1 I2
1.
N
H
F
O
NH
O
–F 7.569 298.9 10.0 1.370 6.361 4.959 2.385 0 0
2.
N
H
F
O
N
O
Et –F 7.824 330.0 18.0 1.330 6.323 5.004 2.367 0 0
3.
N
H
F
O
N
O
(CH2)cPr
–F 6.951 344.0 10.0 1.350 6.419 5.097 2.361 0 0
4.
N
H
O
N
O
H
–F 8.000 294.5 5.0 1.330 6.300 5.099 2.361 0 0
5.
N
H
O
N
O
Me
–F 7.770 309.4 10.0 1.310 6.253 5.099 2.353 0 0
6.
N
H
O
N
O
Et
–F 7.523 325.6 11.0 1.290 6.262 4.969 2.345 0 0
7.
N
H
O
N
O
n-Pr
–F 7.215 341.7 12.0 1.270 6.321 4.925 2.339 0 0
8.
N
H
O
N
O
i-Pr
–F 8.097 342.3 18.0 1.270 6.262 4.968 2.339 0 0
(continued on next page)
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Table 1 (continued)
S. No. R1 R2 pKi MV BAC D WA Id Xeq I1 I2
9.
N
H
O
N
O
(CH2)cPr
–F 7.585 339.6 5.0 1.310 6.362 5.065 2.341 0 0
10.
N
H
O
N
O
i-Bu
–F 6.735 358.4 19.0 1.250 6.364 5.047 2.333 0 0
11.
N
H
O
N
O
cBu
–F 7.553 339.6 5.0 1.310 6.307 5.065 2.341 0 0
12.
N
H
O
N
O
(CH2)2CF3
–F 6.469 356.7 29.0 1.370 6.565 5.116 2.400 0 0
13.
N
H
O
N
O
Bz
–F 6.173 367.9 5.0 1.310 6.617 5.187 2.348 0 0
14.
O
N
H
N
H O
–F 8.097 278.3 5.0 1.360 6.175 5.099 2.370 0 0
15.
O
N
Me
N
H O
–F 8.046 293.3 10.0 1.340 6.128 5.099 2.361 0 0
16.
O
N
Et
N
H O
–F 8.097 309.4 11.0 1.310 6.140 5.099 2.353 0 0
17.
O
N
(CH2)cPr
N
H O
–F 7.824 323.5 5.0 1.330 6.246 5.022 2.348 1 0
18.
O
N
(CH2)cPr
N
H O
–F 8.222 323.5 5.0 1.330 6.246 5.022 2.348 1 0
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Table 1 (continued)
S. No. R1 R2 pKi MV BAC D WA Id Xeq I1 I2
19.
O
N
(CH2)cPr
N
H O –F 8.301 323.5 5.0 1.330 6.246 5.022 2.348 1 0
20.
O
N
cBu
N
H O
–F 7.201 323.5 5.0 1.330 6.190 4.977 2.348 0 0
21.
O
N
i-Bu
N
H O
–F 6.210 342.3 19.0 1.270 6.248 5.004 2.339 0 1
22.
O
N
(CH2)cHex
N
H O
–F 5.906 371.8 5.0 1.270 6.511 5.147 2.330 0 0
23.
O
N
Bz
N
H O
–F 7.509 351.8 5.0 1.330 6.511 5.107 2.355 0 0
24.
O
N
H
N
H O
–CN 7.886 283.1 6.0 1.360 6.372 4.923 2.363 0 0
25.
O
N
(CH2)cPr
N
H O
–CN 7.602 328.2 6.0 1.340 6.432 5.065 2.343 1 0
26.
O
N
(CH2)cPr
N
H O
–CN 7.770 328.2 6.0 1.340 6.432 5.065 2.343 1 0
27.
O
N
(CH2)cPr
N
H O
–CN 7.921 328.2 6.0 1.340 6.432 5.065 2.343 1 0
28.
O
N
H
N
H O
–F 7.699 294.5 5.0 1.330 6.576 4.923 2.361 0 0
29.
O
N
(CH2)cPr
N
H O
–F 6.857 339.6 5.0 1.310 6.627 5.065 2.341 0 0
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Table 3 Comparison between observed and predicted activ-
ities and their residual values.
S. No. Observed Calculated Residual
1. 7.569 7.789 0.220
2. 7.824 7.459 0.365
3. 6.951 7.075 0.124
4. 8.000 7.919 0.081
5. 7.770 7.811 0.041
6. 7.523 7.578 0.055
7. 7.215 7.269 0.054
8. 8.097 7.383 0.714
9. 7.585 7.198 0.387
10. 6.735 7.007 0.272
11. 7.553 7.283 0.270
12. 6.469 6.771 0.302
13. 6.173 6.411 0.238
14. 8.097 8.337 0.240
15. 8.046 8.228 0.182
16. 8.097 7.991 0.106
17. 7.824 8.114 0.290
18. 8.222 8.114 0.108
19. 8.301 8.114 0.187
20. 7.201 7.687 0.486
21. 6.210 6.210 0.000
22. 5.906 6.521 0.615
23. 7.509 6.798 0.711
24. 7.886 7.970 0.084
25. 7.602 7.766 0.164
26. 7.770 7.766 0.004
27. 7.921 7.766 0.155
28. 7.699 7.491 0.208
29. 6.857 6.788 0.069
Table 2 Correlation matrix between physicochemical parameters and indicator parameters.
pKi MV BAC D ID WA Xeq I1 I2
pKi 1.000
MV 0.712 1.000
BAC 0.300 0.292 1.000
D 0.378 0.526 0.202 1.000
ID 0.307 0.348 0.089 0.072 1.000
WA 0.550 0.486 0.034 0.070 0.229 1.000
Xeq 0.141 0.407 0.330 0.763 0.012 0.056 1.000
I1 0.374 0.031 0.315 0.241 0.011 0.051 0.221 1.000
I2 0.370 0.118 0.312 0.307 0.115 0.144 0.164 0.097 1.000
y = 0.7813x + 1.6334
R2 = 0.7813
5.5
6
6.5
7
7.5
8
8.5
5.5 6 6.5 7 7.5 8 8.5
Observed pKi
C
al
cu
la
te
d 
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i
Figure 1 A plot showing comparison between observed and
calculated pKi values using model 1.
410 A.K. Srivastava, N. ShuklapKi ¼ 0:018ð0:007ÞMVþ 0:009ð0:029ÞBAC
 0:956ð2:425ÞIdþ 0:558ð0:389ÞI1
 1:046ð0:863ÞI2 þ 17:899 ð4Þ
n ¼ 29; R ¼ 0:845; R2 ¼ 0:714;
R2A ¼ 0:651; SE ¼ 0:387; Fð5;23Þ ¼ 11:460; Q ¼ 2:183
In all the above models n is the number of data points, R is the
correlation coefﬁcient of determination, SE is the standard er-
ror of estimate,R2A represents adjustedR
2 or explained variance
F is variance ratio (Diudea, 2000) between observed and calcu-
lated activity. Q is the quality of ﬁt (Pogliani, 1994, 1996) and
data within parenthesis are for the 95% conﬁdence intervals.
From the above regression equations it is clear that the po-
sitive coefﬁcient of parameter BAC in above models indicate
that this parameter has positive inﬂuence in determining the
activity. The negative coefﬁcients of Id, WA, MV and D imply
that less bulkier groups having lesser molar volume and den-
sity should be preferred for the future drug designing. But
the negative sign of Xeq shows that less electro negative group
may be favorable for the activity.
The positive sign of coefﬁcient I1 makes it clear that
O
N
(CH2)cPr
N
H O
group at R1 position is beneﬁcial for the activity, while nega-
tive coefﬁcients of I2 explain that
O
N
i-Bu
N
H O
at R1 should be strictly avoided in the future drug modeling.
Predicted and residual values for the best model equation (1)
are given in Table 3. In this equation the F ratio value is much
higher than the theoretical F value [F(5,23) = 2.64] indicating
the statistical signiﬁcance of this equation. Predicted values
are the calculated activities of the equation and the residual val-
ues are the difference between the observed biological activities
and the calculated activities, which are found to be low.
The plot of observed pKi versus predicted pKi based on Eq.
(1) is shown in graph (Fig. 1) and the predicted R2 was found
to be fairly large.
Table 4 Cross-validated parameters and predictive error of coefﬁcient of correlation (PE) for the proposed model.
S. No. Parameters used n PRESS SSY PRESS/SSY R2cv PSE R 1  R2 PE 6PE
1. MV+ BAC+WA+ I1 + I2 29 2.625 9.375 0.280 0.720 0.301 0.884 0.219 0.027 0.162
2. MV+ BAC+Xeq + I1 + I2 29 3.059 8.941 0.342 0.658 0.325 0.863 0.255 0.032 0.192
3. MV+ BAC+ D+ I1 + I2 29 3.142 8.858 0.355 0.645 0.329 0.859 0.262 0.032 0.192
4. MV+ BAC+ ID+ I1 + I2 29 3.437 8.563 0.401 0.599 0.344 0.845 0.286 0.035 0.210
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The cross-validation analysis was performed using leave one
out (LOO) method (Carmer et al., 1988; Podloga and Fergu-
son, 2000), in which one compound is removed from the data-
set and the activity is correlated using the rest of the dataset.
The cross-validated R2 in each case was found to be very close
to the value of R2 for the entire dataset and hence these models
can be termed as statistically signiﬁcant.
Cross-validation provides the values of predicted residual
sum of squares (PRESS), sum of the squares of the response
(SSY) and R2cv (overall predicted ability) and predicted
squares error (PSE) from which we can test the predictive
power of the proposed model. It is argued that PRESS is a
good estimate of the real predictive error of the model and
if it is smaller than SSY the model predicts better than chance
and can be considered statistically signiﬁcant. Furthermore,
the ratio PRESS/SSY can be used to calculate approximate
conﬁdence intervals of prediction of new compound. To be
a reasonable QSAR model PRESS/SSY should be smaller
than 0.4. Also, if PRESS value is transformed in a dimension-
less term by relating it to the initial sum of squares, we obtain
R2cv, i.e. the complement to the traces of unexplained variance
over the total variance. The PRESS and R2cv have good prop-
erties. However, for practical purposes of end users the use of
square root of PRESS/N, which is called predictive square er-
ror (PSE), is more directly related to the uncertainty of the
predictions. The PSE values also support our results. The cal-
culated cross-validated parameters conﬁrm the validity of the
models. All the requirements for an ideal model have been
fulﬁlled by model No. 1, that is why we have considered it
as the best model.
R2A takes into account the adjustment of R
2. R2A is a mea-
sure of the percentage explained variation in the dependent
variable that takes into account the relationship between the
number of cases and the number of independent variables in
the regression model, whereas R2 will always increase when
an independent variable is added. R2A will decrease if the added
variable does not reduce the unexplained variable enough to
offset the loss of decrease of freedom.
3.2. Predictive error of coefﬁcient of correlation (PE)
The predictive error of coefﬁcient of correlation (PE) (Chatter-
jee et al., 2000) is yet another parameter used to decide the pre-
dictive power of the proposed models. We have calculated PE
value of all the proposed models and they are reported in Ta-
ble 4. It is argued that of
(i) R< PE, then correlation is not signiﬁcant;
(ii) R> PE; several times (at least three times), then corre-
lation is indicated; and if
(iii) R> 6PE, then the correlation is deﬁnitely good.(iv) For all the models developed the condition R> 6PE is
satisﬁed and hence they can be said to have a good pre-
dictive power.4. Conclusions
From the results and discussion made above, it may be con-
cluded that:
(1) Less polar, smaller groups having lesser molar volume
and density should be used in future drug designing.
(2) The group
O
N
(CH2)cPr
N
H O
at R1 position favors the inhibitory activity.
(3) Group
O
N
i-Bu
N
H O
at R1 position, respectively, should be avoided in future
drug modeling.
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